Deal Announcements

Applied Genetic Lands Venture Capital Debt

Monday, May 07, 2012 5:58:00 AM PDT | VentureDeal Staff

   Alachua, Florida  --  Biotechnology company Applied Genetic Technologies has secured $750,000 in new venture capital debt financing, according to an SEC regulatory filing.

Applied Genetic is developing a treatment for Alpha One Antitrypsin Deficiency, an inherited cause of emphysema.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1